As these drugs gain notoriety because of their weight-loss side effects, both drugmakers sales have grown significantly
Thanks wedgewood See replies from fbirder and Hidden which answer my question Apologies if my question wasn't clear to you Thanks Fbirder and Beginner1 for your posts The three months supply seems to me totally arbitrary
GLP-1 drug shows little benefit for people with Parkinsons disease 5 February 2025 The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinsons disease, finds a new study led by UCL researchers
Persistent Gastrointestinal Symptoms : Inability to maintain adequate oral intake due to severe nausea or vomiting lasting more than 24-48 hours necessitates medical attention
In either case, its important to make changes only with your providers supervision, since dosing, timing, and monitoring can differ